Market news
Detailed price information for Boston Scientific Corp (BSX-N) from The Globe and Mail including charting and trades.
Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.
In a regulatory filing on August 10, pharmaceutical titan Merck & Company, Inc. (NYSE:MRK) disclosed holding 1,214,126 shares of micro-cap AI immunology firm Evaxion A/S (NASDAQ:EVAX). Evaxion shares bumped up 2% to $3.17 in early trading on the news. The position follows Merck’s September 2025 decision to exercise its option to in-license EVX-B3, Evaxion’s discovery-stage […]
Detailed price information for Evaxion A/S ADR (EVAX-Q) from The Globe and Mail including charting and trades.
This is the newest page. Registered accounts read further back.